University of oxford's kennedy institute of rheumatology partners with absci to accelerate ai-driven immunotherapies

Absci will apply its generative ai platform to the kennedy institute's immunology biorepository to speed the discovery and development of multiple therapies absci will apply its generative ai platform to the kennedy institute's immunology biorepository to speed the discovery and development of multiple therapies
ABSI Ratings Summary
ABSI Quant Ranking